Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2025
Download Free Sample Buy Now
Global Chronic Myeloid Leukemia (CML) Treatment Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2025

By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types), By Application (Hospitals, Clinic, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Chronic Myeloid Leukemia (CML) Treatment Market Overview

• Chronic Myeloid Leukemia (CML) Treatment market size has reached to $8.23 billion in 2024

• Expected to grow to $11.32 billion in 2029 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Rising Incidence Of Chronic Myeloid Leukemia (CML)

• Market Trend: Innovation In Drug Development For Better Treatment

• North America was the largest region in 2024.

What Is Covered Under Chronic Myeloid Leukemia (CML) Treatment Market?

Chronic myeloid leukemia (CML) treatment refers to the treatment of chronic myeloid leukemia. Cancer of the blood and bone marrow is called chronic myeloid leukemia (CML). It is characterized by the uncontrolled growth of abnormal white blood cells called myeloid cells. These cells are usually responsible for fighting infections and maintaining the body's immune system.

The main types of chronic myeloid leukemia (CML) treatment are targeted therapy, chemotherapy, radiation therapy, splenectomy, and stem cell transplant. Targeted therapy refers to a type of cancer treatment where drugs are used to specifically target the genes and proteins that support the growth and survival of cancer cells. Targeted therapy in chronic myeloid leukemia (CML) treatment is used to recognize and destroy particular cancer cell types while sparing healthy cells for injury. The various drugs include tyrosine kinase inhibitors, antimetabolites, and others that are used in hospitals, clinics, and others. The medicines related to chronic myeloid leukemia (CML) treatment are available in hospital pharmacies, retail pharmacies, and online pharmacies.

Chronic Myeloid Leukemia (CML) Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Chronic Myeloid Leukemia (CML) Treatment Market Size 2025 And Growth Rate?

The chronic myeloid leukemia (CML) treatment market size has grown strongly in recent years. It will grow from $8.23 billion in 2024 to $8.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increased awareness and early detection, clinical trial outcomes, targeted therapies development, patient advocacy and support groups, healthcare infrastructure development

What Is The Chronic Myeloid Leukemia (CML) Treatment Market Growth Forecast?

The chronic myeloid leukemia (CML) treatment market size is expected to see strong growth in the next few years. It will grow to $11.32 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine approaches, combination therapies, increasing patient access to novel therapies, government policies supporting orphan drugs, rising healthcare expenditure. Major trends in the forecast period include global collaboration in research, telemedicine and remote monitoring, development of next-generation tkis, treatment optimization strategies.

The forecast of 7.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. oncology by increasing the cost of tyrosine kinase inhibitors and BCR-ABL polymerase chain reaction(PCR) test kits sourced from Switzerland and the Netherlands, thereby compromising molecular remission rates and elevating cancer treatment expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Chronic Myeloid Leukemia (CML) Treatment Market Segmented?

1) By Type: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant

2) By Drug Type: Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types

3) By Application: Hospitals, Clinic, Other Applications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Other Targeted Agents

2) By Chemotherapy: Combination Regimens, Single-Agent Therapies

3) By Radiation Therapy: Palliative Radiation, Total Body Irradiation

4) By Splenectomy: Laparoscopic Splenectomy, Open Splenectomy

5) By Stem Cell Transplant: Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant

What Is Driving The Chronic Myeloid Leukemia (CML) Treatment Market? Rising Incidence Of Chronic Myeloid Leukemia (CML)

The rising incidence and prevalence of chronic myeloid leukemia (CML) population is expected to propel the growth of the chronic myeloid leukemia (CML) treatment market going forward. Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the overproduction of immature white blood cells called myeloid cells. Chronic myeloid leukemia (CML) treatment helps to slow the progression of cancer and stop it from reaching an advanced phase. For instance, in March 2023, according to the American Society of Clinical Oncology, a US-based professional organization representing physicians of all oncology sub-specialties, in the United States, in 2023, around 35,730 persons (19,860 men and 15,870 women) are anticipated to receive a multiple myeloma diagnosis and 12,590 deaths from this illness are anticipated in 2023 (7,000 males and 5,590 women). Therefore, the rising incidence and prevalence of chronic myeloid leukemia (CML) population is driving the growth of the chronic myeloid leukemia (CML) treatment industry going forward.

What Is Driving The Chronic Myeloid Leukemia (CML) Treatment Market? Growing Demand For Personalized Medicine

The development of personalized medicine has contributed to the growth of the chronic myeloid leukemia (CML) treatment market. Personalized medicine aids doctors in designing individualized treatment plans and making treatment decisions based on a genetic understanding of the patient's disease. Personalized medicine in CML involves identifying specific molecular targets, particularly the BCR-ABL fusion gene. This allows for a more precise understanding of the genetic abnormalities driving the disease in each patient. enabling early intervention and personalized preventive measures. For instance, in February 2023, according to the Personalized Medicine Coalition (PMC), a US-based non-profit umbrella organization, personalized medicines tailored for specific patient subpopulations with distinct biological traits represented 34 percent of new drug approvals in 2022 by the U.S. Food and Drug Administration (FDA). Therefore, the development of personalized medicine is expected to drive the growth of the chronic myeloid leukemia (CML) treatment industry.

Who Are The Major Players In The Global Chronic Myeloid Leukemia (CML) Treatment Market?

Major companies operating in the chronic myeloid leukemia (CML) treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Orca Bio, Bio-Path Holdings Inc.

What Are The Key Trends Of The Global Chronic Myeloid Leukemia (CML) Treatment Market? Innovation In Drug Development For Better Treatment

Product Innovation is a key trend gaining popularity in the chronic myeloid leukemia (CML) treatment market. Companies operating in the chronic myeloid leukemia (CML) treatment market are adopting new technologies to sustain their position in the market. For instance, in August 2022, Novartis AG, a Switzerland-based pharmaceutical company, announced the European Commission (EC) approval for Scemblix for the management of adult patients with chronic myeloid leukemia in the chronic phase (Ph+ CML-CP), which is chromosome-positive. Scemblix is the first treatment for chronic myeloid leukemia (CML) in Europe that specifically targets the ABL myristoyl pocket, a feature known as a STAMP inhibitor in scientific literature. This innovative mechanism provides a new treatment option for patients who have developed intolerance or resistance to existing tyrosine kinase inhibitors (TKIs). By reimagining the treatment approach, Scemblix addresses the needs of those who struggle with current therapies.

What Are The Key Trends Of The Global Chronic Myeloid Leukemia (CML) Treatment Market? Strategic Partnership To Propel The Market Need

Companies in the chronic myeloid leukemia (CML) treatment market are focusing on partnerships and collaborations to expand their product portfolio and geographic presence. For example, in February 2023 Xspray Pharma a Sweden based Biotechnology company has partnered with EVERSANAa US- based life sciences industry. to support the US launch and commercialization of its product, Dasynoc (XS004), for the treatment of chronic myeloid leukemia (CML) and acute lymphatic leukemia (ALL). Dasynoc is a new and differentiated treatment option for CML and ALL patients, pending FDA-approval and legal conditions. The product is expected to enter the $3.5 billion commercial market for Tyrosine Kinase Inhibitors in the United States, The partnership with EVERSANA will provide Xspray with a dedicated commercialization team with deep experience in the oncology market, allowing for a customized approach to the commercialization of Dasynoc. The launch of Dasynoc is aimed at the second half of 2023, and it is expected to significantly improve the treatment options for CML and ALL patients in the US.

Need data on a specific region in this market?
Request Regional Data

Chronic Myeloid Leukemia (CML) Treatment Market Merger And Acquisition: Bristol Myers Squibb Acquired Turning Point Therapeutics

In August 2022, Bristol Myers Squibb., a US-based multinational pharmaceutical company, acquired Turning Point Therapeutics for $4.1 billion. With this acquisition, Bristol Myers Squibb gains access to a pipeline of experimental drugs including repotrectinib that aim to block the most prevalent mutations linked to oncogenesis. Turning Point Therapeutics is a US-based pharmaceutical company that develops precision medicines for cancer and other diseases including tyrosine kinase inhibitors which are used in the treatment of chronic myeloid leukemia (CML).

Regional Outlook For The Global Chronic Myeloid Leukemia (CML) Treatment Market

North America was the largest region in the chronic myeloid leukemia (CML) treatment market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Myeloid Leukemia (CML) Treatment Market?

The chronic myeloid leukemia (CML) treatment market includes revenues earned by entities by providing targeted therapy with tyrosine kinase inhibitors (TKIs). The chronic myeloid leukemia market includes Imatinib, Dasatinib, Nilotinib, Bosutinib, Ponatinib, and Asciminib. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Chronic Myeloid Leukemia (CML) Treatment Industry?

The chronic myeloid leukemia (cml) treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic myeloid leukemia (cml) treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Chronic Myeloid Leukemia (CML) Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.64 billion
Revenue Forecast In 2034 $11.32 billion
Growth Rate CAGR of 7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant
2) By Drug Type: Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types
3) By Application: Hospitals, Clinic, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Other Targeted Agents
2) By Chemotherapy: Combination Regimens, Single-Agent Therapies
3) By Radiation Therapy: Palliative Radiation, Total Body Irradiation
4) By Splenectomy: Laparoscopic Splenectomy, Open Splenectomy
5) By Stem Cell Transplant: Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Orca Bio, Bio-Path Holdings Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Chronic Myeloid Leukemia (CML) Treatment Market Characteristics

3. Chronic Myeloid Leukemia (CML) Treatment Market Trends And Strategies

4. Chronic Myeloid Leukemia (CML) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chronic Myeloid Leukemia (CML) Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Myeloid Leukemia (CML) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Chronic Myeloid Leukemia (CML) Treatment Market Growth Rate Analysis

5.4. Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Chronic Myeloid Leukemia (CML) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Chronic Myeloid Leukemia (CML) Treatment Total Addressable Market (TAM)

6. Chronic Myeloid Leukemia (CML) Treatment Market Segmentation

6.1. Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Therapy

Chemotherapy

Radiation Therapy

Splenectomy

Stem Cell Transplant

6.2. Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors

Antimetabolites

Other Drug Types

6.3. Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinic

Other Applications

6.4. Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors (TKIs)

Other Targeted Agents

6.6. Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Regimens

Single-Agent Therapies

6.7. Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Palliative Radiation

Total Body Irradiation

6.8. Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Splenectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laparoscopic Splenectomy

Open Splenectomy

6.9. Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allogeneic Stem Cell Transplant

Autologous Stem Cell Transplant

7. Chronic Myeloid Leukemia (CML) Treatment Market Regional And Country Analysis

7.1. Global Chronic Myeloid Leukemia (CML) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Chronic Myeloid Leukemia (CML) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market

8.1. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Myeloid Leukemia (CML) Treatment Market

9.1. China Chronic Myeloid Leukemia (CML) Treatment Market Overview

9.2. China Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Myeloid Leukemia (CML) Treatment Market

10.1. India Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Myeloid Leukemia (CML) Treatment Market

11.1. Japan Chronic Myeloid Leukemia (CML) Treatment Market Overview

11.2. Japan Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Myeloid Leukemia (CML) Treatment Market

12.1. Australia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Myeloid Leukemia (CML) Treatment Market

13.1. Indonesia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Myeloid Leukemia (CML) Treatment Market

14.1. South Korea Chronic Myeloid Leukemia (CML) Treatment Market Overview

14.2. South Korea Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Myeloid Leukemia (CML) Treatment Market

15.1. Western Europe Chronic Myeloid Leukemia (CML) Treatment Market Overview

15.2. Western Europe Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Myeloid Leukemia (CML) Treatment Market

16.1. UK Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Myeloid Leukemia (CML) Treatment Market

17.1. Germany Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Myeloid Leukemia (CML) Treatment Market

18.1. France Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Myeloid Leukemia (CML) Treatment Market

19.1. Italy Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Myeloid Leukemia (CML) Treatment Market

20.1. Spain Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Myeloid Leukemia (CML) Treatment Market

21.1. Eastern Europe Chronic Myeloid Leukemia (CML) Treatment Market Overview

21.2. Eastern Europe Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Myeloid Leukemia (CML) Treatment Market

22.1. Russia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Myeloid Leukemia (CML) Treatment Market

23.1. North America Chronic Myeloid Leukemia (CML) Treatment Market Overview

23.2. North America Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Myeloid Leukemia (CML) Treatment Market

24.1. USA Chronic Myeloid Leukemia (CML) Treatment Market Overview

24.2. USA Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Myeloid Leukemia (CML) Treatment Market

25.1. Canada Chronic Myeloid Leukemia (CML) Treatment Market Overview

25.2. Canada Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Myeloid Leukemia (CML) Treatment Market

26.1. South America Chronic Myeloid Leukemia (CML) Treatment Market Overview

26.2. South America Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Myeloid Leukemia (CML) Treatment Market

27.1. Brazil Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Myeloid Leukemia (CML) Treatment Market

28.1. Middle East Chronic Myeloid Leukemia (CML) Treatment Market Overview

28.2. Middle East Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Myeloid Leukemia (CML) Treatment Market

29.1. Africa Chronic Myeloid Leukemia (CML) Treatment Market Overview

29.2. Africa Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Myeloid Leukemia (CML) Treatment Market Competitive Landscape And Company Profiles

30.1. Chronic Myeloid Leukemia (CML) Treatment Market Competitive Landscape

30.2. Chronic Myeloid Leukemia (CML) Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Myeloid Leukemia (CML) Treatment Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Bristol-Myers Squibb Company

31.3. AstraZeneca plc

31.4. Takeda Pharmaceutical Company Limited

31.5. Amgen Inc.

31.6. Viatris Inc.

31.7. Teva Pharmaceutical Industries Ltd.

31.8. Eisai Co. Ltd.

31.9. Fresenius Kabi AG

31.10. Sun Pharmaceutical Industries Ltd.

31.11. Otsuka Pharmaceutical Co. Ltd.

31.12. Incyte Corporation

31.13. Cipla Limited

31.14. Dr. Reddy's Laboratories Ltd.

31.15. Amneal Pharmaceuticals LLC

32. Global Chronic Myeloid Leukemia (CML) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Myeloid Leukemia (CML) Treatment Market

34. Recent Developments In The Chronic Myeloid Leukemia (CML) Treatment Market

35. Chronic Myeloid Leukemia (CML) Treatment Market High Potential Countries, Segments and Strategies

35.1 Chronic Myeloid Leukemia (CML) Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Chronic Myeloid Leukemia (CML) Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Chronic Myeloid Leukemia (CML) Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Splenectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Chronic Myeloid Leukemia (CML) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Chronic Myeloid Leukemia (CML) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: AbbVie Inc. Financial Performance
  • Table 84: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Splenectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Chronic Myeloid Leukemia (CML) Treatment Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Chronic Myeloid Leukemia (CML) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Chronic Myeloid Leukemia (CML) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Chronic Myeloid Leukemia (CML) Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: AbbVie Inc. Financial Performance
  • Figure 84: Bayer AG Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

Read More About Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Antimetabolit...

View Report

Chronic Myeloid Leukemia Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of ...

View Report

Chronic Myeloid Leukemia Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of ...

View Report

Leukemia Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymp...

View Report

Chronic Lymphocytic Leukemia Treatment Global Market Report 2025 – By Type (Aggressive CLL, Indolent CLL, Other Types), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route ...

View Report

Acute Myeloid Leukemia Global Market Report 2025 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-me...

View Report

Myeloproliferative Disorders Drugs Global Market Report 2025 – By Type (Primary Myelofibrosis, Polycythemia Vera (PV), Essential Thrombocythemia (ET), Chronic Eosinophilic Leukemia Or Hyper eosinophilic Syndrome (HES), S...

View Report

Leqembi Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (Injectable Formulation (Intravenous), Ready-To-Use Solutions), By Indication (Treatment Of Alzh...

View Report

Frequently Asked Questions

Chronic myeloid leukemia (CML) treatment refers to the treatment of chronic myeloid leukemia. Cancer of the blood and bone marrow is called chronic myeloid leukemia (CML). It is characterized by the uncontrolled growth of abnormal white blood cells called myeloid cells. These cells are usually responsible for fighting infections and maintaining the body's immune system. For further insights on this market, request a sample here

The market major growth driver - Rising Incidence Of Chronic Myeloid Leukemia (CML). For further insights on this market, request a sample here

The chronic myeloid leukemia (cml) treatment market size has grown strongly in recent years. It will grow from $8.23 billion in 2024 to $8.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increased awareness and early detection, clinical trial outcomes, targeted therapies development, patient advocacy and support groups, healthcare infrastructure development. The chronic myeloid leukemia (cml) treatment market size is expected to see strong growth in the next few years. It will grow to " $11.32 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine approaches, combination therapies, increasing patient access to novel therapies, government policies supporting orphan drugs, rising healthcare expenditure. Major trends in the forecast period include global collaboration in research, telemedicine and remote monitoring, development of next-generation tkis, treatment optimization strategies. For further insights on this market, request a sample here

The chronic myeloid leukemia (cml) treatmentmarket covered in this report is segmented –
1) By Type: Targeted Therapy; Chemotherapy; Radiation Therapy; Splenectomy; Stem Cell Transplant
2) By Drug Type: Tyrosine Kinase Inhibitors; Antimetabolites; Other Drug Types
3) By Application: Hospitals; Clinic; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Subsegments:
1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Other Targeted Agents
2) By Chemotherapy: Combination Regimens; Single-Agent Therapies
3) By Radiation Therapy: Palliative Radiation; Total Body Irradiation
4) By Splenectomy: Laparoscopic Splenectomy; Open Splenectomy
5) By Stem Cell Transplant: Allogeneic Stem Cell Transplant; Autologous Stem Cell Transplant For further insights on this market, request a sample here

North America was the largest region in the chronic myeloid leukemia (CML) treatment market in 2024. The regions covered in the chronic myeloid leukemia (CML) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the chronic myeloid leukemia (CML) treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Orca Bio, Bio-Path Holdings Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovation In Drug Development For Better Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Chronic Myeloid Leukemia (CML) Treatment Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon